Loading...
Loading...
BlackRock Health Sciences Trust
BlackRock Health Sciences Trust. Spoken Alpha tracks BME's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BME's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BME.
curl https://api.spokenalpha.com/v1/companies/BME| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.83 | $1.13 | -26.7% | +1.1% | -1.4% |
| Q4 FY2026 | $0.99 | $1.23 | -19.2% | -7.3% | -5.1% |
| Q3 FY2026 | $0.95 | $1.24 | -23.3% | -4.6% | -4.1% |
| Q2 FY2026 | $1.12 | $1.43 | -21.4% | 0.0% | +2.6% |
| Q1 FY2025 | $0.99 | $1.40 | -29.3% | -1.4% | -3.1% |
| Q4 FY2025 | $0.98 | $1.21 | -19.3% | -2.2% | -4.2% |
| Q3 FY2025 | $0.92 | $1.27 | -27.8% | +0.1% | -2.4% |
| Q2 FY2025 | $1.00 | $1.26 | -20.7% | -1.3% | +0.5% |
| Q1 FY2024 | $0.88 | $1.28 | -31.2% | +2.4% | +2.0% |
| Q4 FY2024 | $1.18 | $1.54 | -23.3% | +1.0% | +1.2% |